Table 10 Patient characteristics focusing on structural CMR results
MD | LGE-negative | LGE-positive | p value | |
|---|---|---|---|---|
N = 63 | N = 15 | N = 48 | ||
Male, n (%) | 63 (100) | 15 (100) | 48 (100) | 1.00 |
Age, years | 31 ± 15 | 25 ± 17 | 32 ± 14 | 0.13 |
BMD, n (%) | 51 (81) | 14 (93) | 37 (77) | 0.26 |
BMI, kg/m2 | 24 ± 4 | 23 ± 5 | 24 ± 4 | 0.38 |
Skeletal muscle status 0/1/2/3, n (%) | 2 (3)/43 (68)/13 (21)/5 (8) | 2 (13)/11 (73)/1 (7)/1 (7) | 32 (67)/12 (25)/4 (8)/0 (0) | 0.06 |
ACE inhibitor, n (%) | 16 (25) | 1 (7) | 15 (31) | 0.09 |
Beta-blocker, n (%) | 14 (22) | 1 (7) | 13 (27) | 0.16 |
CK, U/L | 1226 (653–2424) | 773 (607–2187) | 1358 (797-2481) | 0.18 |
Elevated hs-trop, n (%)a | 30 (48) | 2 (13) | 28 (58) | 0.003 |
Elevated NT-proBNP, n (%)b | 3 (5) | 0 (0) | 3 (6) | 1.00 |